These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7925617)

  • 1. Molecular modeling of adenosine receptors. The ligand binding site on the rat adenosine A2A receptor.
    IJzerman AP; van der Wenden EM; van Galen PJ; Jacobson KA
    Eur J Pharmacol; 1994 Jun; 268(1):95-104. PubMed ID: 7925617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling of adenosine receptors. I. The ligand binding site on the A1 receptor.
    IJzerman AP; Van Galen PJ; Jacobson KA
    Drug Des Discov; 1992; 9(1):49-67. PubMed ID: 1457698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition.
    Jiang Q; Van Rhee AM; Kim J; Yehle S; Wess J; Jacobson KA
    Mol Pharmacol; 1996 Sep; 50(3):512-21. PubMed ID: 8794889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A carboxyl-terminally truncated mutant and nonglycosylated A2a adenosine receptors retain ligand binding.
    Piersen CE; True CD; Wells JN
    Mol Pharmacol; 1994 May; 45(5):861-70. PubMed ID: 8190103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptor.
    Kim J; Wess J; van Rhee AM; Schöneberg T; Jacobson KA
    J Biol Chem; 1995 Jun; 270(23):13987-97. PubMed ID: 7775460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenesis reveals structure-activity parallels between human A2A adenosine receptors and biogenic amine G protein-coupled receptors.
    Jiang Q; Lee BX; Glashofer M; van Rhee AM; Jacobson KA
    J Med Chem; 1997 Aug; 40(16):2588-95. PubMed ID: 9258366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A binding site model and structure-activity relationships for the rat A3 adenosine receptor.
    van Galen PJ; van Bergen AH; Gallo-Rodriguez C; Melman N; Olah ME; IJzerman AP; Stiles GL; Jacobson KA
    Mol Pharmacol; 1994 Jun; 45(6):1101-11. PubMed ID: 8022403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modeling the human A1 adenosine receptor and study of the mechanisms of its selective ligand binding.
    Ivanov AA; Baskin II; Palyulin VA; Zefirov NS
    Dokl Biochem Biophys; 2002; 386():271-4. PubMed ID: 12469507
    [No Abstract]   [Full Text] [Related]  

  • 9. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes.
    Link AA; Kino T; Worth JA; McGuire JL; Crane ML; Chrousos GP; Wilder RL; Elenkov IJ
    J Immunol; 2000 Jan; 164(1):436-42. PubMed ID: 10605040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of histidine residues in the adenosine A2a receptor ligand binding site.
    Askalan R; Richardson PJ
    J Neurochem; 1994 Oct; 63(4):1477-84. PubMed ID: 7931300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further characterization of [3H]-CGS 21680 binding sites in the rat striatum and cortex.
    Kirk IP; Richardson PJ
    Br J Pharmacol; 1995 Jan; 114(2):537-43. PubMed ID: 7881753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cysteine residues of rat A2a adenosine receptors in agonist binding.
    Mazzoni MR; Giusti L; Rossi E; Taddei S; Lucacchini A
    Biochim Biophys Acta; 1997 Feb; 1324(1):159-70. PubMed ID: 9059509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding thermodynamics of adenosine A2a receptor ligands.
    Borea PA; Dalpiaz A; Varani K; Guerra L; Gilli G
    Biochem Pharmacol; 1995 Feb; 49(4):461-9. PubMed ID: 7532939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer aided comparative analysis of the binding modes of the adenosine receptor agonists for all known subtypes of adenosine receptors.
    Ivanov AA; Palyulin VA; Zefirov NS
    J Mol Graph Model; 2007 Jan; 25(5):740-54. PubMed ID: 17095272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
    Li AH; Moro S; Forsyth N; Melman N; Ji XD; Jacobson KA
    J Med Chem; 1999 Feb; 42(4):706-21. PubMed ID: 10052977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological and biochemical characterization of purified A2a adenosine receptors in human platelet membranes by [3H]-CGS 21680 binding.
    Varani K; Gessi S; Dalpiaz A; Borea PA
    Br J Pharmacol; 1996 Apr; 117(8):1693-701. PubMed ID: 8732278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors.
    Dalpiaz A; Townsend-Nicholson A; Beukers MW; Schofield PR; IJzerman AP
    Biochem Pharmacol; 1998 Dec; 56(11):1437-45. PubMed ID: 9827575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of the human A3 adenosine receptor.
    Gao ZG; Chen A; Barak D; Kim SK; Müller CE; Jacobson KA
    J Biol Chem; 2002 May; 277(21):19056-63. PubMed ID: 11891221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
    Cunha RA; Johansson B; Constantino MD; Sebastião AM; Fredholm BB
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A2A receptor agonists: CoMFA-based selection of the most predictive conformation.
    Doytchinova I; Valkova I; Natcheva R
    SAR QSAR Environ Res; 2002 Mar; 13(2):227-35. PubMed ID: 12071651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.